Since ACE2 is a cellular receptor of SARS-CoV-2 and is also involved in hypertension that delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19 [30], this conclusion may need to be verified with more COVID-19 cases and among multiple human populations, such as CHB, EUR, and Yoruba in Ibadan, Nigeria. The gene discussed is ACE2; the disease is COVID-19.